No connection

Search Results

Regulatory Score 75 Bullish

Novo Nordisk Shares Climb Following NICE Recommendation for Wegovy in Cardiovascular Prevention

Apr 01, 2026 08:47 UTC
NVO, SPY, EEM
Immediate term

Novo Nordisk's stock rose after England's drug price regulator endorsed Wegovy for preventing heart attacks and strokes. The recommendation is expected to boost NHS access and sales.

  • NICE recommended Wegovy for cardiovascular prevention in adults with a BMI of at least 27 and a history of heart issues.
  • Wegovy's active ingredient, semaglutide, is also used in Ozempic for diabetes treatment.
  • Novo Nordisk's shares rose up to 4% following the recommendation, with a 2% gain in morning trading.
  • The Stoxx 600 index increased by 2.1% as the pharmaceutical sector responded positively.
  • The recommendation is expected to expand NHS access to Wegovy, potentially boosting sales.

Novo Nordisk's shares climbed as much as 4% following a recommendation from England's National Institute for Health and Care Excellence (NICE) to use its drug Wegovy for preventing heart attacks and strokes. The endorsement, which came as the company's Copenhagen-listed stock was seen up 2% in morning trading, reflects a significant regulatory milestone for the pharmaceutical giant. Wegovy, primarily marketed as a weight loss treatment, is also approved for reducing the risk of major cardiovascular events in individuals with overweight or obesity. NICE, which evaluates the cost-effectiveness of medications, recommended semaglutide—the active ingredient in Wegovy and Ozempic—as an option for adults with a history of heart attacks, strokes, or severe leg circulation issues and a BMI of at least 27. The decision is expected to expand access to the drug through the National Health Service (NHS), potentially increasing sales and market confidence. The pan-European Stoxx 600 index rose 2.1% in response to the positive regulatory news.

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Create Free Account Already have an account? Sign In
Share this article

Related Articles

Score 25

Trump to Attend Supreme Court Birthright Citizenship Arguments

Apr 01, 10:22

Score 75

EU Proposes Carbon Market Adjustments to Curb Energy Costs

Apr 01, 10:02

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Get Started Free View Plans
Features Terminal AI Assistant Analysis Market News Pricing
Start Trading with AI Already have an account? Sign In
Home
Terminal
AI
Markets
Profile